Molecular biology studies have shown that human peripheral blood lymphocyte
s express a dopamine D5 receptor, whereas no information is available on do
pamine DI receptor, the other dopamine D1-like receptor subtype. Radioligan
d binding assay investigations with the nonsubtype selective dopamine D1-li
ke receptor antagonist [H-3]SCH 23390 as radioligand have suggested the pre
sence of a dopamine D5 receptor in human peripheral blood lymphocytes. Howe
ver. so far no evidence was provided as whether or not human peripheral blo
od lymphocytes express a dopamine D1 receptor. In this study, we have inves
tigated dopamine D1 and D5 receptor mRNA and the influence of antibodies ag
ainst dopamine D1 and D5 receptors on [H-3]SCH 23390 binding to intact huma
n peripheral blood lymphocytes. The two receptors were also analyzed by imm
unocytochemistry. Dopamine D5 receptor, but not D1 mRNA, was detected in hu
man peripheral blood lymphocytes. Anti-dopamine D5 receptor antibodies, but
not anti-dopamine D1 receptor antibodies, significantly decreased [H-3]SCH
23390 binding to human peripheral blood lymphocytes. A dark-brown immunore
activity was visualized in cytospin centrifuged human peripheral blood lymp
hocytes exposed to anti-dopamine D5, but not to anti-dopamine D1 receptor a
ntibodies. These data collectively indicate that dopamine D5 receptor is th
e only dopamine D1-like receptor subtype expressed by human peripheral bloo
d lymphocytes. (C) 1999 Elsevier Science. All rights reserved.